Six-minute walk test in children and adolescents with cystic fibrosis

Pediatric Pulmonology

Volumn 41, Issue 7, 2006, Pages 618-622

  Cunha, Maristela Trevisan ^a   Rozov, Tatiana ^a   De Oliveira, Rosangela Caitano ^a   Jardim, José R ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

6 min walk test; Child; Cystic fibrosis; Work

Indexed keywords

ADOLESCENT; ARTERIAL PRESSURE; ARTICLE; BODY MASS; BREATHING MUSCLE; CHILD; CLINICAL ARTICLE; CYSTIC FIBROSIS; DIAGNOSTIC TEST; EXERCISE TOLERANCE; FEMALE; HEART RATE; HUMAN; MALE; MUSCLE STRENGTH; OXYGEN SATURATION; PHYSICAL CAPACITY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REPRODUCIBILITY; SIX MINUTE WALK TEST; TASK PERFORMANCE; WALKING;

ADOLESCENT; CHILD; CYSTIC FIBROSIS; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; REPRODUCIBILITY OF RESULTS; TIME FACTORS; WALKING;

EID: 33745686516     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20308     Document Type: Article

References (40)

1. Orenstein DM, Noyes BE. Cystic fibrosis. In: Casaburi R, Petly TL, editors. Principles and practice of pulmonary rehabilitation. Philadelphia: W.B. Saunders Co.; 1994. p 439-458.
2. Elbora S. The management of young adults with cystic fibrosis: "genes, jeans and genies." Disabil Rehabil 1998;20:217-225.
3. Mikkilineni S. Pulmonary rehabilitation in pediatric patients. In: Cherniack NS, Altose MD, Homma I, editors. Rehabilitation of the patient with respiratory disease. New York: McGraw-Hill; 1999. p 631-642.
4. American Thoracic Society. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-117.
5. Perepech NB, Kutuzova AE, Nedoshivin AO. Six-minute walking test for the evaluation of the status of patients with chronic cardiac failure. Klin Med (Mosk) 2000;78:31-33.
6. Gulmans VAM, Veldhoven NHMJ, Meer K, Helders PJM. The six-minute walking test in children with cystic fibrosis: reliability and validity. Pediatr Pulmonol 1996;22:85-89.
7. Guillén MAJ, Posadas AS, Asensi JRV, Moreno RMG, Rodríguez N, González AS. Reproductibilidad del test de la marcha (walking test) en pacientes afectos de fibrosis quistica. An Esp Pediatr 1999;51:475-478.
8. Chuang ML, Lin IF, Wasserman K. The body weight-walking distance product as related to lung function, anaerobic threshold and peak VO2 in COPD patients. Respir Med 2001;95:618-626.
9. American Thoracic Society. Standardization of spirometry. 1994 update. Am J Respir Crit Care Med 1995;152:1107-1136.
10. Borg GAV. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982;14:377-381.
11. Johnson WR, Buskirk ER. Asthma. Science and medicine of exercise and sport. 2nd ed. New York: Harper & Row; 1974. p 644.
12. Shwachman H, Kulczycki LL. Long-term study of one hundred and five patients with cystic fibrosis: studies made over a five to fourteen year period. Am J Dis Child 1958;96:6-15.
13. Bland J, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310.
14. Hulley SB, Cummings SR, Browner WS, Grady D, Hearst N, Newman TB. Designing clinical research: an epidemiologic approach. 2nd ed. Baltimore: Lippincott Williams & Wilkins; 2001. p 336.
15. Ogden CL, Kuczmarski RJ, Flegal KM, Mei Z, Guo S, Wei R, Grummer-Strawn LM, Curtin LR, Roche AF, Johnson CL. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 2002;109:45-60.
16. Gaultier C, Zinman R. Maximal static pressures in healthy children. Respir Physiol 1983;51:45-61.
17. Smyth RJ, Chapman KR, Rebuk AS. Maximal inspiratory and expiratory pressures in adolescents. Chest 1984;86:568-572.
18. Boucher GP, Lands LC, Hay JA, Hornby L. Activity levels and the relationship to lung functional nutritional status in children with cystic fibrosis. Am J Phys Med Rehabil 1997;76:311-315.
19. Nixon PA, Joswiak ML, Fricker J. A six-minute walk test for assessing exercise tolerance in severely ill children. J Pediatr 1996;129:362-366.
20. Upton CJ, Tyrrel JC, Hiller EJ. Two minute walking distance in cystic fibrosis. Arch Dis Child 1988;63:1444-1448.
21. O'Donnell DE. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstrutive pulmonary disease. Am J Crit Care Med 1999;160:542-549.
22. Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J 1999;14:270-274.
23. Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med 1998;158:1384-1387.
24. Escobar M, López A, Véliz C, Crisóstomo S, Pinochet R. Test de marcha en 6 minutes en niños chilenos sanos. Kinesiologia 2001;62:16-20.
25. Cavalheiro LV, Cendon SP, Ferreira IM, Ribeiro AS, Gastaldi A, Jardim JR. Six-minute walking test accompanied by a physiotherapist assesses better the physical capacity of patients with COPD. Am J Respir Crit Care Med 1997;155:167.
26. Carter R, Holiday DB, Nwasuruba C, Stocks J, Grothues C, Tiep B. Six-minute walk work for assessment of functional capacity in patients with COPD. Chest 2003;123:1408-1415.
27. Weiner P, Magadle R, Beckerman M, Weiner M, Berar-Yanay N. Specific expiratory muscle training in COPD. Chest 2003;124:468-473.
28. Weiner P, Magadle R, Beckerman M, Weiner M, Berar-Yanay N. Comparison of specific expiratory, inspiratory, and combined muscle training programs in COPD. Chest 2003;124:1357-1364.
29. Ceray FJ, Pullano TP, Cropp GJA. Cardiorespiratory adaptations to exercise in cystic fibrosis. Am Rev Respir Dis 1982;126:217-220.
30. Godoy I, Campana AO, Geraldo RR, Padovani CR, Paiva SA. Cytokines and dietary energy restriction in stable chronic obstructive pulmonary disease patients. Eur Respir J 2003;22:920-925.
31. Wouters EF, Creutzberg EC, Schols AM. Systemic effects in COPD. Chest 2002;121:127-130.
32. Eid AA, Ionescu AA, Nixon LS, Lewis-Jenkins V, Matthews SB, Griffiths TL, Shale DJ. Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:1414-1418.
33. Warner JO. Immunology of cystic fibrosis. Br Med Bull 1992;48:893-911.
34. Tirakitsoontorn P, Nussbaum E, Moser C, Hill M, Cooper DM. Fitness, acute exercise, and anabolic and catabolic mediators in cystic fibrosis. Am J Respir Crit Care Med 2001;164:1432-1437.
35. Nixon PA, Orenstein DM, Kelsey SF, Doershuk CF. The prognostic value of exercise testing in patients with cystic fibrosis. N Engl J Med 1992;327:1785-1788.
36. Pike SE, Prasad SA, Balfour-Lynn IM. Effect of intravenous antibiotics on exercise tolerance (3-min step test) in cystic fibrosis. Pediatr Pulmonol 2001;32:38-43.
37. Bradley J, McAlister O, Elborn S. Pulmonary function, inflammation, exercise capacity and quality of life in cystic fibrosis. Eur Respir J 2001;17:712-715.
38. Bernard RS, Cohen LL. Increasing adherence to cystic fibrosis treatment: a systematic review of behavioral techniques. Pediatr Pulmonol 2004;37:8-16.
39. Prasad SA, Cerny FJ. Factors that influence adherence to exercise and their effectiveness: application to cystic fibrosis. Pediatr Pulmonol 2002;34:66-72.
40. Orenstein DM, Franklin BA, Doershuk CF, Hellerstein HK, Germann KJ, Horowitz JG, Stem RC. Exercise conditioning and cardiopulmonary fitness in cystic fibrosis. The effects of a three-month supervised running program. Chest 1981;80:392-398.